Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Molecular determinants of the estrogen receptor-coactivator interface.

Mak HY, Hoare S, Henttu PM, Parker MG.

Mol Cell Biol. 1999 May;19(5):3895-903.

2.

Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation.

McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG.

Genes Dev. 1998 Nov 1;12(21):3357-68.

3.
4.
5.

Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.

Gee AC, Carlson KE, Martini PG, Katzenellenbogen BS, Katzenellenbogen JA.

Mol Endocrinol. 1999 Nov;13(11):1912-23.

PMID:
10551784
6.

Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.

Northrop JP, Nguyen D, Piplani S, Olivan SE, Kwan ST, Go NF, Hart CP, Schatz PJ.

Mol Endocrinol. 2000 May;14(5):605-22.

PMID:
10809226
7.
8.

A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Heery DM, Kalkhoven E, Hoare S, Parker MG.

Nature. 1997 Jun 12;387(6634):733-6.

PMID:
9192902
10.

Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain.

Razeto A, Ramakrishnan V, Litterst CM, Giller K, Griesinger C, Carlomagno T, Lakomek N, Heimburg T, Lodrini M, Pfitzner E, Becker S.

J Mol Biol. 2004 Feb 13;336(2):319-29.

PMID:
14757047
12.
13.

Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.

Bramlett KS, Wu Y, Burris TP.

Mol Endocrinol. 2001 Jun;15(6):909-22.

PMID:
11376110
14.

Communication between the ERRalpha homodimer interface and the PGC-1alpha binding surface via the helix 8-9 loop.

Greschik H, Althage M, Flaig R, Sato Y, Chavant V, Peluso-Iltis C, Choulier L, Cronet P, Rochel N, Schüle R, Strömstedt PE, Moras D.

J Biol Chem. 2008 Jul 18;283(29):20220-30. doi: 10.1074/jbc.M801920200. Epub 2008 Apr 25.

15.
16.

Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine.

White R, Sjöberg M, Kalkhoven E, Parker MG.

EMBO J. 1997 Mar 17;16(6):1427-35.

17.

Both coactivator LXXLL motif-dependent and -independent interactions are required for peroxisome proliferator-activated receptor gamma (PPARgamma) function.

Chen S, Johnson BA, Li Y, Aster S, McKeever B, Mosley R, Moller DE, Zhou G.

J Biol Chem. 2000 Feb 11;275(6):3733-6.

18.

Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA.

Delage-Mourroux R, Martini PG, Choi I, Kraichely DM, Hoeksema J, Katzenellenbogen BS.

J Biol Chem. 2000 Nov 17;275(46):35848-56.

19.

An LXXLL motif in the transactivation domain of STAT6 mediates recruitment of NCoA-1/SRC-1.

Litterst CM, Pfitzner E.

J Biol Chem. 2002 Sep 27;277(39):36052-60. Epub 2002 Jul 22.

20.

Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.

Chang Cy, Norris JD, Grøn H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP.

Mol Cell Biol. 1999 Dec;19(12):8226-39.

Items per page

Supplemental Content

Write to the Help Desk